Trial Profile
Bemiparin as a Thromboprophylaxis After Benign Gynaecological Surgeries: A Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2015
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 01 Aug 2013 Planned End Date changed from 1 Sep 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 01 Feb 2013 Planned End Date changed from 1 Feb 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 04 Jul 2012 New trial record